Total submissions: 25
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000174491 | SCV000169107 | benign | not specified | 2013-10-23 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ambry Genetics | RCV000163377 | SCV000213917 | likely benign | Hereditary cancer-predisposing syndrome | 2014-11-02 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Eurofins Ntd Llc |
RCV000174491 | SCV000225800 | likely benign | not specified | 2014-12-08 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000205713 | SCV000261678 | benign | Tuberous sclerosis 2 | 2025-02-04 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000174491 | SCV000305141 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000042948 | SCV000395574 | benign | Tuberous sclerosis syndrome | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Center for Pediatric Genomic Medicine, |
RCV000429983 | SCV000511452 | benign | not provided | 2016-07-13 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000174491 | SCV000597591 | likely benign | not specified | 2015-08-28 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000205713 | SCV000677534 | benign | Tuberous sclerosis 2 | 2017-05-30 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000429983 | SCV000697459 | benign | not provided | 2016-08-23 | criteria provided, single submitter | clinical testing | Variant summary: The c.1281C>A (p.Ile427=) in TSC2 gene is a synonymous change that involves a non-conserved nucleotide. 5/5 programs in Alamut predict that this variant does not affect normal splicing, however no functional studies supporting this notion were published at the time of evaluation. The variant is present in the control population dataset of ExAC at frequency of 0.0022 (201/93004 chrs tested), predominantly in individuals of European descent (0.0032; 161/50172). This frequency exceeds the estimated maximum allele frequency for a pathogenic allele in this gene (0.0000068). The variant of interest has been cited as Benign/Likely Benign by multiple reputable databases/clinical laboratories. Taking together, based on the prevalence of this variant in general population the variant was classified as Benign. |
Ce |
RCV000429983 | SCV001150687 | likely benign | not provided | 2024-12-01 | criteria provided, single submitter | clinical testing | TSC2: BP4, BP7 |
ARUP Laboratories, |
RCV000429983 | SCV001470957 | benign | not provided | 2024-11-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000205713 | SCV002041145 | benign | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000163377 | SCV002532763 | likely benign | Hereditary cancer-predisposing syndrome | 2021-03-12 | criteria provided, single submitter | curation | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000174491 | SCV002774064 | benign | not specified | 2021-12-03 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002496678 | SCV002804437 | likely benign | Lymphangiomyomatosis; Isolated focal cortical dysplasia type II; Tuberous sclerosis 2 | 2022-04-06 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000205713 | SCV004360859 | benign | Tuberous sclerosis 2 | 2022-09-20 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV000042948 | SCV004819245 | benign | Tuberous sclerosis syndrome | 2024-02-05 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV000205713 | SCV005881410 | benign | Tuberous sclerosis 2 | 2025-02-01 | criteria provided, single submitter | clinical testing | |
Tuberous sclerosis database |
RCV000042948 | SCV000066745 | not provided | Tuberous sclerosis syndrome | no assertion provided | curation | ||
Tuberous sclerosis database |
RCV000055284 | SCV000083504 | not provided | Lymphangiomyomatosis | no assertion provided | curation | ||
Genome Diagnostics Laboratory, |
RCV000429983 | SCV001808645 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000429983 | SCV001922603 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000174491 | SCV001975931 | benign | not specified | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000429983 | SCV001979779 | likely benign | not provided | no assertion criteria provided | clinical testing |